United States, Sept. 16 -- Octapharma USA LLC, Paramus, New Jersey, is awarded a sole-source, firm-fixed-price, indefinite-quantity/indefinite-delivery contract (HT9425-25-D-E004) valued at $14,880,000 in support of the Defense Health Agency Program Executive Office Operational Medicine for the purchase of OctaplasLG Kits. All kits are to be delivered to either the Armed Services Whole Blood Processing Laboratory - East or Armed Services Whole Blood Processing Laboratory - West. The period of performance is Sept. 15, 2025, to Sept. 14, 2030. The place of performance is Fort Detrick, Maryland. Fiscal 2025 operation and maintenance funds are obligated at the time of award. The Defense Health Agency, U.S. Army Medical Research Acquisition Acti...